RECIPHARM
Live / Registered — Registered — Section 71 accepted (as of 31 May 2023)
What this means for you
Registered since 29 Nov 2011. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79089041
- Registration number
- 4061976
- Mark type
- Design + words
- Filed
- 23 Sept 2010
- Published for opposition
- 13 Sept 2011
- Registered
- 29 Nov 2011
- Attorney of record
- Richard J. McKenna
Goods and services
- Class 005 — Pharmaceuticals: [ Pharmaceutical preparations, namely, antibacterial pharmaceuticals, anti-diabetic pharmaceuticals, balms for pharmaceutical purposes, cardiovascular pharmaceuticals, dermatological pharmaceutical products, digestives for pharmaceutical purposes, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders, ocular pharmaceuticals, pharmaceutical anti-allergic preparations and substances, pharmaceutical anti-allergic preparations and substances, anticoagulants, antidepressants, appetite suppressants, pharmaceutical preparations for use in chemotherapy, pharmaceutical preparations for the treatment of heart rhythm disorders, pharmaceutical preparations for the treatment of infectious diseases, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for wounds, pharmaceutical preparations for use in urology, pharmaceutical preparations for skin care, pharmaceutical preparations for the treatment of kidney diseases, pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders, and pharmaceutical preparations for the treatment of the thyroid gland ]
- Class 042 — Scientific and technological services: [ Medical research laboratory services; ] [ consultation services related to research in the field of development of surgical products; ] [ product development; development of medical products; and ] scientific and technological services and research and design relating thereto for medical purposes, namely, medical and scientific research in the fields of [ cancer treatment, cardiovascular treatment, treatment of infectious diseases, and ] treatment of a wide variety of major medical human disorders
Owner
- Recipharm AB (publ), STOCKHOLM, SE
- Recipharm AB (publ), Jordbro, SE
- Recipharm AB (publ), Jordbro, SE
Prosecution history
- 17 Mar 2024 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 07 Feb 2024 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 07 Feb 2024 — INVALIDATION PROCESSED
- 31 Jan 2024 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 31 May 2023 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 31 May 2023 — REGISTERED-SEC.71 ACCEPTED
- 17 Apr 2023 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 02 Nov 2022 — POST REGISTRATION ACTION MAILED - SEC.71
- 24 Oct 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 May 2022 — TEAS SECTION 71 RECEIVED
- 29 Nov 2020 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 06 Nov 2020 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 30 Oct 2020 — INTERNATIONAL REGISTRATION RENEWED
- 12 Oct 2018 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 05 Sept 2018 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB